A Randomized, Open-Label Study of the Efficacy and Safety of Aralast NP, an Alpha-1 Antitrypsin Infusion Therapy With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection
This is a Randomized, Open-Label Study of the Efficacy and Safety of Aralast NP Infusion Therapy with Antiviral Treatment and standard of care versus Antiviral Treatment and standard of care (control group) in Hospitalized Patients with Pneumonia and COVID-19 Infection.
100 项与 Blessing Corporate Services 相关的临床结果
0 项与 Blessing Corporate Services 相关的专利（医药）
100 项与 Blessing Corporate Services 相关的药物交易
100 项与 Blessing Corporate Services 相关的转化医学
